Ocho Cinco benched for breaking team rule
The Cincinnati Bengals say Chad Ocho Cinco, the wide receiver formerly known as Chad Johnson, will be deactivated for Thursday night's game with the Pittsburgh Steelers for violating a team rule.
NYT: Daschle poses conflict-of-interest test
The choice of Tom Daschle for secretary of health and human services poses questions about how broadly Barack Obama will apply campaign promises to limit conflicts of interest among appointees.
ConsumerMan: Shady retirement seminars
Many Americans nearing retirement are bombarded with invitations to attend financial management seminars. A free lunch is offered. But that lunch may prove to be pricey.
Oil hits 3-year low; gas at $2 in 23 states
Oil prices on hit levels not seen in more than three years and retail gas prices are now below $2 across nearly half of the country on dour reports suggesting an economic pullback.
eHarmony agrees to provide same-sex matches
Online dating service eHarmony said Wednesday it will launch a new Web site which caters to same-sex singles as part of a discrimination settlement with New Jersey's Civil Rights Division.
Jobless claims jump to 16-year high
New claims for unemployment benefits jumped last week to a 16-year high, the Labor Department said Thursday, providing more evidence of a rapidly weakening job market.
Deflation poses economic threat
Strapped consumers are rejoicing at falling prices. But some economists warn of the growing risk of a ruinous downward price spiral called deflation. Here's what's at stake.
Napolitano up for Homeland Security
An early Barack Obama supporter from the southwestern part of the country, the former Arizona attorney general is a leading contender for the job of secretary of homeland security.
Michael Jackson to testify in London
Michael Jackson's lawyer says the pop star has agreed to come to London to respond to a Bahraini sheik's $7 million lawsuit.
EpiPens: life-saving kid accessory
As allergies to peanuts, milk, eggs and gluten have risen, a cult-like following has emerged around the EpiPen, a single-shot of medication that can halt a potentially deadly reaction.
